Yabao Pharmaceutical Group Co Ltd Financial Flexibility Index
Yabao Pharmaceutical Group Co Ltd financial flexibility index. Yabao Pharmaceutical Group Co Ltd (600351) has a Financial Flexibility Index of 0.23x as of September 2025. Free cash flow of CN¥137.07 Million (operating CF CN¥129.49 Million minus capex CN¥7.58 Million) represents 0% of total liabilities (CN¥585.77 Million). See how much free cash does Yabao Pharmaceutical Group Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Yabao Pharmaceutical Group Co Ltd (2001–2024)
Financial flexibility index of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. Historical Financial Flexibility Index trend for Yabao Pharmaceutical Group Co Ltd across 24 annual periods. Check 600351 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Yabao Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (2001–2024)
Yabao Pharmaceutical Group Co Ltd financial flexibility index by year from 2001 to 2024. Year-by-year free cash flow to debt coverage for Yabao Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 600351 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.78x | CN¥506.36 Million | CN¥471.69 Million | CN¥649.02 Million | ▲ +12.4% |
| 2023 | 0.69x | CN¥597.41 Million | CN¥497.55 Million | CN¥860.33 Million | ▲ +49.4% |
| 2022 | 0.46x | CN¥522.69 Million | CN¥460.46 Million | CN¥1.12 Billion | ▼ -2.8% |
| 2021 | 0.48x | CN¥532.56 Million | CN¥437.50 Million | CN¥1.11 Billion | ▲ +28.9% |
| 2020 | 0.37x | CN¥443.83 Million | CN¥380.96 Million | CN¥1.20 Billion | ▲ +1.2% |
| 2019 | 0.37x | CN¥582.26 Million | CN¥425.17 Million | CN¥1.59 Billion | ▲ +34.4% |
| 2018 | 0.27x | CN¥494.61 Million | CN¥426.60 Million | CN¥1.81 Billion | ▲ +51.9% |
| 2017 | 0.18x | CN¥261.07 Million | CN¥161.73 Million | CN¥1.45 Billion | ▲ +10.2% |
| 2016 | 0.16x | CN¥240.42 Million | CN¥155.95 Million | CN¥1.48 Billion | ▲ +4.6% |
| 2015 | 0.16x | CN¥245.14 Million | CN¥143.47 Million | CN¥1.57 Billion | ▼ -39.7% |
| 2014 | 0.26x | CN¥352.47 Million | CN¥178.63 Million | CN¥1.37 Billion | ▲ +149.6% |
| 2013 | 0.10x | CN¥155.82 Million | CN¥56.80 Million | CN¥1.51 Billion | ▲ +1383.4% |
| 2012 | 0.01x | CN¥8.85 Million | CN¥-96.73 Million | CN¥1.27 Billion | ▼ -95.2% |
| 2011 | 0.14x | CN¥160.28 Million | CN¥40.73 Million | CN¥1.11 Billion | ▲ +0.1% |
| 2010 | 0.14x | CN¥205.87 Million | CN¥18.57 Million | CN¥1.43 Billion | ▼ -70.4% |
| 2009 | 0.49x | CN¥638.39 Million | CN¥368.56 Million | CN¥1.31 Billion | ▲ +64.1% |
| 2008 | 0.30x | CN¥250.46 Million | CN¥102.90 Million | CN¥843.93 Million | ▲ +50.4% |
| 2007 | 0.20x | CN¥136.99 Million | CN¥105.69 Million | CN¥694.23 Million | ▲ +141.2% |
| 2006 | 0.08x | CN¥55.29 Million | CN¥11.59 Million | CN¥675.74 Million | ▼ -52.8% |
| 2005 | 0.17x | CN¥135.35 Million | CN¥26.40 Million | CN¥780.42 Million | ▼ -63.2% |
| 2004 | 0.47x | CN¥282.54 Million | CN¥79.73 Million | CN¥599.65 Million | ▲ +122.1% |
| 2003 | 0.21x | CN¥73.55 Million | CN¥-9.62 Million | CN¥346.67 Million | ▼ -30.4% |
| 2002 | 0.30x | CN¥51.67 Million | CN¥24.29 Million | CN¥169.57 Million | ▲ +10.8% |
| 2001 | 0.27x | CN¥46.63 Million | CN¥23.59 Million | CN¥169.58 Million | — |